Multiple Manufacturers

ALPHANATE

Manufacturer:

Multiple Manufacturers

Alphanate HCPCS:

J7186

HCPCS Code Descriptor:

Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.

Category:

J Code

Alphanate NDCs:

68516-4620-02, 68516-4616-01, 68516-4618-02, 68516-4617-01, 68516-4619-02, 68516-4611-01, 68516-4612-01, 68516-4615-02, 68516-4614-02, 68516-4613-02, 68516-4609-02, 68516-4604-02, 68516-4601-01, 68516-4603-02, 68516-4602-01

Primary Type:

Hematology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

68516-4602-01, 68516-4609-02, 68516-4604-02, 68516-4601-01, 68516-4603-02

About Alphanate:

ALPHANATE is a Hematology drug manufactured by Grifols and administered via the Intravenous route of administration. The J Code: J7186 is aligned to the drug ALPHANATE.

ACCESS PRICING AND MORE BY REGISTERING

J7186 Added Date:

January 1, 2009

J7186 Effective Date:

January 1, 2009

J7186 Termination Date:

HCPCS Active

Alphanate billing and coding information can be found through Grifols at the link below:
Alphanate patient assistance information can be found through Grifols Pharmaceuticals at the URL: https://www.alphanate.com/en/patients/support-and-resources/factors-for-health
Our team is still working to identify a prescribing information source for ALPHANATE
Our team has not yet identified a source of side effects information for ALPHANATE. Please check back in a few weeks.